Literature DB >> 21948057

Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group.

A Ghezzi1, R Carone, G Del Popolo, M P Amato, A Bertolotto, M Comola, U Del Carro, P Di Benedetto, A Giannantoni, M L Lopes de Carvalho, E Montanari, F Patti, A Protti, S Rasia, A Salonia, C Scandellari, F Sperli, M Spinelli, C Solaro, A Uccelli, M Zaffaroni, V Zipoli.   

Abstract

Urinary disorders are uncommon in the initial phases of multiple sclerosis, but increase in frequency as the disease progresses, with a negative impact on quality of life. The goal of this study was to propose a protocol for the diagnosis and treatment of urinary disorders in multiple sclerosis, based on data from the scientific literature and the experience of Italian clinical centres. In particular, the following clinical aspects were considered: what to do with patients with asymptomatic multiple sclerosis; what to do with symptomatic patients; how and when to perform a second-level diagnostic evaluation; and how to treat urinary disorders. A diagnostic-therapeutic algorithm is proposed, that can be applied in Italian clinical centres.

Entities:  

Mesh:

Year:  2011        PMID: 21948057     DOI: 10.1007/s10072-011-0794-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  23 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

Review 2.  Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology.

Authors:  Paolo Di Benedetto; Cristina Delneri; Emanuele Biasutti; Luisa Monti Bragadin; Tullio Giorgini
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

3.  [Afferent stimulation of the tibial nerve in patients with hyperactive bladder].

Authors:  G G Krivoborodov; E B Mazo; P G Shvarts
Journal:  Urologiia       Date:  2002 Sep-Oct

4.  Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction.

Authors:  M W Nortvedt; T Riise; K M Myhr; A M Landtblom; A Bakke; H I Nyland
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

5.  Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.

Authors:  R B C Kavia; D De Ridder; C S Constantinescu; C G Stott; C J Fowler
Journal:  Mult Scler       Date:  2010-09-09       Impact factor: 6.312

Review 6.  Multiple sclerosis and the urologist.

Authors:  S E Litwiller; E M Frohman; P E Zimmern
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

7.  Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study.

Authors:  Sibel Canbaz Kabay; Mehmet Yucel; Sahin Kabay
Journal:  Urology       Date:  2008-04       Impact factor: 2.649

8.  Pelvic floor rehabilitation is effective in patients with multiple sclerosis.

Authors:  T Vahtera; M Haaranen; A L Viramo-Koskela; J Ruutiainen
Journal:  Clin Rehabil       Date:  1997-08       Impact factor: 3.477

Review 9.  A UK consensus on the management of the bladder in multiple sclerosis.

Authors:  C J Fowler; J N Panicker; M Drake; C Harris; S C W Harrison; M Kirby; M Lucas; N Macleod; J Mangnall; A North; B Porter; S Reid; N Russell; K Watkiss; M Wells
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

10.  Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis.

Authors:  E L Koldewijn; O R Hommes; W A Lemmens; F M Debruyne; P E van Kerrebroeck
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

View more
  17 in total

1.  The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.

Authors:  Bhupendra O Khatri; John F Foley; Jennifer Fink; John F Kramer; Choon Cha; Xiaojun You; John D Warth; Pam Foulds
Journal:  Int J MS Care       Date:  2014

Review 2.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 3.  Treatment of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017-03-16       Impact factor: 1.862

Review 4.  Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.

Authors:  Ryuji Sakakibara
Journal:  Clin Auton Res       Date:  2018-08-03       Impact factor: 4.435

5.  Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.

Authors:  A Ghezzi; E Mutta; F Bianchi; S Bonavita; F Buttari; A Caramma; R Cavarretta; D Centonze; G C Coghe; G Coniglio; U Del Carro; M T Ferrò; M G Marrosu; F Patti; M Rovaris; M Sparaco; I Simone; C Tortorella; R Bergamaschi
Journal:  Neurol Sci       Date:  2015-11-27       Impact factor: 3.307

6.  THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.

Authors:  Giorgia Teresa Maniscalco; R Aponte; D Bruzzese; G Guarcello; V Manzo; M Napolitano; O Moreggia; F Chiariello; C Florio
Journal:  Neurol Sci       Date:  2017-10-19       Impact factor: 3.307

Review 7.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

8.  Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.

Authors:  David Bates; Jack Burks; Denise Globe; Manuel Signori; Stacie Hudgens; Pierre Denys; Scott Macdiarmid; Victor Nitti; Ib Odderson; Amy Perrin Ross; Michael Chancellor
Journal:  BMC Neurol       Date:  2013-07-09       Impact factor: 2.474

Review 9.  Overactive bladder - 18 years - Part I.

Authors:  Jose Carlos Truzzi; Cristiano Mendes Gomes; Carlos A Bezerra; Ivan Mauricio Plata; Jose Campos; Gustavo Luis Garrido; Fernando G Almeida; Marcio Augusto Averbeck; Alexandre Fornari; Anibal Salazar; Arturo Dell'Oro; Caio Cintra; Carlos Alberto Ricetto Sacomani; Juan Pablo Tapia; Eduardo Brambila; Emilio Miguel Longo; Flavio Trigo Rocha; Francisco Coutinho; Gabriel Favre; Jose Antonio Garcia; Juan Castano; Miguel Reyes; Rodrigo Eugenio Leyton; Ruiter Silva Ferreira; Sergio Duran; Vanda Lopez; Ricardo Reges
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

Review 10.  The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.

Authors:  Jure Tornic; Jalesh N Panicker
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-28       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.